Related references
Note: Only part of the references are listed.Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention
Daniel A. Nation et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
Michael A. Weber et al.
JOURNAL OF CLINICAL HYPERTENSION (2014)
Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease
Yoshiko Furiya et al.
ALZHEIMERS & DEMENTIA (2013)
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis
Natacha Levi Marpillat et al.
JOURNAL OF HYPERTENSION (2013)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults
Daniel A. Nation et al.
NEUROLOGY (2013)
Risk Factors for β-Amyloid Deposition in Healthy Aging
Karen M. Rodrigue et al.
JAMA NEUROLOGY (2013)
MRI predictors of cognitive change in a diverse and carefully characterized elderly population
Owen Carmichael et al.
NEUROBIOLOGY OF AGING (2012)
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons
Jessica B. S. Langbaum et al.
NEUROBIOLOGY OF AGING (2012)
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
Craig Anderson et al.
LANCET NEUROLOGY (2011)
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
Mark W. J. Strachan et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Elevated pulse pressure is associated with age-related decline in language ability
D. A. Nation et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2010)
Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization
R. C. Petersen et al.
NEUROLOGY (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension Results From the Cardiovascular Health Study
Kaycee M. Sink et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Hypertension and cerebrovascular damage
Franco Veglio et al.
ATHEROSCLEROSIS (2009)
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
Albert Fournier et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension
Maria Teresa Gentile et al.
NEUROBIOLOGY OF AGING (2009)
Duration of antihypertensive drug use and risk of dementia A prospective cohort study
M. D. M. Haag et al.
NEUROLOGY (2009)
Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
L. B. Hoffman et al.
NEUROLOGY (2009)
Angiotensins in Alzheimer's disease - friend or foe?
Patrick G. Kehoe et al.
TRENDS IN NEUROSCIENCES (2009)
Hypertension, cognitive decline and dementia
E. Duron et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2008)
Hypertension and cerebrovascular dysfunction
Costantino Iadecola et al.
CELL METABOLISM (2008)
Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore longitudinal study of aging
Shari R. Waldstein et al.
HYPERTENSION (2008)
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
Clifford R. Jack et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease
Bruce R. Reed et al.
BRAIN (2007)
Update on hypertension and Alzheimer's disease
Ingmar Skoog et al.
NEUROLOGICAL RESEARCH (2006)
Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan
T Ohrui et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation
M Iwai et al.
CIRCULATION (2004)
Influence of losartan and atenolol on memory function in very elderly hypertensive patients
R Fogari et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Inflammation and angiotensin II
Y Suzuki et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older - A community-based, longitudinal study
CX Qiu et al.
STROKE (2003)
The relation of hypertension to cognitive function
SR Waldstein
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE (2003)
Effects of hypertension on attention, memory, and executive function in older adults
BK Saxby et al.
HEALTH PSYCHOLOGY (2003)
Organisation and functional role of the brain angiotensin system
C Llorens-Cortes et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2002)
Alzheimer disease as a vascular disorder - Nosological evidence
JC de la Torre
STROKE (2002)
What cognitive changes can be expected with normal ageing?
H Christensen
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2001)
Midlife vascular risk factors and late-life mild cognitive impairment -: A population-based study
M Kivipelto et al.
NEUROLOGY (2001)
Cardiovascular risk factors and cognitive decline in middle-aged adults
D Knopman et al.
NEUROLOGY (2001)
Dementia and disability outcomes in large hypertension trials: Lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial
M Di Bari et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)